Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a minor maintenance update to the page version without altering study details.
    Difference
    0.0%
    Check dated 2026-06-27T01:23:36.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's Study Documents section and several blocks listing study locations, investigators, and identifiers have been removed. This reduces visibility of critical trial materials and contact information, affecting the ability to review and engage with the study record.
    Difference
    19%
    Check dated 2026-06-19T23:46:03.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and header adjustments (Intervention/Treatment added; Intervention / Treatment removed) with Revision updated to v3.6.0, and the page now displays 'No longer looking for participants' to reflect closed enrollment.
    Difference
    0.4%
    Check dated 2026-06-12T17:28:39.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new page revision tag Revision: v3.5.5 was added, replacing the previous tag Revision: v3.5.4. This indicates an updated version of the page content or its documentation.
    Difference
    0.0%
    Check dated 2026-06-05T15:59:58.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.5.3 to v3.5.4, signaling a newer version of the page has been published. This is a metadata-level update and does not specify which content was modified.
    Difference
    0.0%
    Check dated 2026-05-15T05:51:45.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page’s release/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a change in the ClinicalTrials.gov page revision, not the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T05:39:25.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.